Sunzen Group Berhad (KLSE:SUNZEN)

Market Cap	193.29M -14.3%
Revenue (ttm)	80.19M -18.3%
Net Income	7.71M +13.3%
EPS	0.01 -6.1%
Shares Out	805.38M
PE Ratio	28.71
Forward PE	n/a
Dividend	0.00 (1.67%)
Ex-Dividend Date	Dec 12, 2025

Volume	85,700
Average Volume	1,752,925
Open	0.2400
Previous Close	0.2400
Day's Range	0.2350 - 0.2400
52-Week Range	0.2200 - 0.3500
Beta	0.28
RSI	46.97
Earnings Date	May 22, 2026

About Sunzen Group Berhad

Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, and beauty and cosmetic products. It also offers financial consultancy services and licensed money lending activities; manufactures and sells tradition...

• Industry: Pharmaceutical Preparations
• Founded: 1998
• Employees: 168
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: SUNZEN

Financial Performance

In fiscal year 2025, Sunzen Group Berhad's revenue was 80.58 million, a decrease of -15.28% compared to the previous year's 95.12 million. Earnings were 2.59 million, a decrease of -57.10%.